AI-Powered symptom watch aims to keep head and neck cancer patients out of the ER

NCT ID NCT05338905

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether using machine learning to closely monitor symptoms can help head and neck cancer patients avoid urgent hospital visits during radiation therapy. Researchers will compare intensive symptom tracking plus standard care to standard care alone in 72 patients with non-metastatic head and neck cancer. The goal is to see if early detection of worsening symptoms leads to better quality of life and fewer emergency visits.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Intensive symptom surveillance with machine learning risk stratification
What this could lead to
If successful, this approach could help doctors catch worsening symptoms earlier and reduce the need for emergency hospital visits during radiation therapy.
What could go wrong
This is a small, early-stage study (72 participants) focused on non-metastatic disease, so results may not apply to all head and neck cancer patients. The intervention is observational and does not test a new drug or treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Roswell Park Cancer Institute

    Buffalo, New York, 14263, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.